Engineers Gate Manager LP

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1620220 NEW YORK, NY

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

19,197

-71.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	19,197	-71.1%	Shares	Sole	2026-05-15
2025-09-30	—	66,336	+13.0%	Shares	Sole	2025-11-14
2025-06-30	—	58,718	+39.2%	Shares	Sole	2025-08-14
2025-03-31	—	42,172	-37.6%	Shares	Sole	2025-05-15
2024-09-30	—	67,625	+455.7%	Shares	Sole	2024-11-14
2024-06-30	—	12,169	+101.2%	Shares	Sole	2024-08-14
2024-03-31	—	6,049	+58.0%	Shares	Sole	2024-05-15
2023-12-31	—	3,828	-85.5%	Shares	Sole	2024-02-14
2023-09-30	—	26,361	+650.0%	Shares	Sole	2023-11-14
2023-06-30	—	3,515	-67.1%	Shares	Sole	2023-08-14
2022-03-31	—	10,678	+41.8%	Shares	Sole	2022-05-16
2021-03-31	—	7,530	-18.9%	Shares	Sole	2021-05-17
2020-12-31	—	9,290	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.